Process validation and drug quality
Drug discovery and design
Innovations In Pharmaceutical Technology
Pharmaceutical Nanotechnology & Nanomedicine and Biomedical Applications
Scope of Pharmaceutical Research
GROWTH OF INDIAN PHARMA SECTOR
The saying “Health is Wealth” is very true in the sense that only if there is health in general and for scientists in particular, the inventions leading to development in the Pharma sector can take place. The term significantly is also true, as we could see that from the traditional healthcare system - Ayurveda, Unani medicines, well known in India and China, the Pharmaceutical industry has come of age to be reckoned with as one of the leading players in Allopathic medicines too domestically and globally to meet the growing export market demands. Though Alembic in Gujarat was one of the oldest small Pharma units to be established way back in 1907 at Baroda, it was M/s. Bengal Chemical and Pharmaceutical Works Limited that came up in the organized sector in the 1930s for producing various pharma formulations in India; it still continues to be in the sector. Since then, there has not been looking back in the growth of Pharma industry in the country.
India continues to play a crucial role in manufacturing various critical, high quality and low-cost medicines for Indian and global markets. It supplies 50 to 60 percent of global demand for vaccines (including ARVs). Over the last 5 years, 35 to 38 percent of total ANDAs approved have been filed from Indian sites. India’s pharmaceutical market has grown rapidly over the last decade. Despite recent headwinds, a stable growth of 5-7% was observed last year. India is likely to become one of the Top 3 pharma markets by 2030.
GUJARAT FOREFRONT IN PHARMA SECTOR
Gujarat Accounting for nearly 42 percent share of India’s pharmaceutical turnover, 22 percent of its drug exports and 20 percent of its chemicals output, Gujarat’s pharmaceutical industry has evolved in to an innovation-driven, knowledge-focused industry. Going forward, to attain a leading position in the global pharma industry.
Growing ease of doing business has shaped Gujarat into one of the most favoured destinations globally for pharmaceutical investments. With introduction of various initiatives and a strong hold in medicine and biotechnology stratum, Gujarat has emerged as a pharmaceutical hub in India.
Profile of Speakers
This will be an ideal platform for those who deal with this sector to promote their products and services. Various sponsorship options are available, each having specific promotional privileges. For more details ask for sponsorship matrix.
To attend the conference, send the Delegate Registration Form, duly filled in, along-with Registration Fees.
Conference Souvenir will be distributed during the conference. And hence, this will be a unique opportunity to promote products and services by releasing advertisement in this souvenir. Various advertisement options are available in advertisement booking form.
Pharma Confex 2018
According to the UBM India report global pharma market is presently estimated to be over $1 trillion in value, of which the US accounts for over 40%, followed by the European Union and Japan. The global pharmaceutical market is divided into patented pharma products and generics. Generics market currently account for over 45% of the global market by volume and about 20% by value. In India, about 70% revenue comes from generics, 21% from over-the-counter drugs and the rest from patented drugs.
Indian pharmaceuticals market is the third largest in terms of volume and 13th largest in terms of value. India’s exports are expected to account for 72% of the total Pharma production and reach a value of $40 billion by 2020. India, currently has second highest number of US Food and Drug Administration (FDA) approved plants after the US and accounts for 22% of overall US FDA approved facilities.
The Indian Pharmaceutical industry has been growing at a compounded annual growth rate (CAGR) of more than 15% over the last five years and has significant growth opportunities. However, for the industry to sustain this growth rate till 2020, companies will have to rethink their business strategy. They will have to follow new business models and think of innovative ideas to service their evolving customers faster and better.
India's cost of production is significantly lower than that of the US and almost half of that of Europe and that gives a competitive edge to India over others. Pharma companies will continue to grow both organically and inorganically through alliances and partnerships. They will continue to focus on improving operational efficiency and productivity. Developments in the health insurance, medical technology and mobile telephony can help the growth of the pharma industry by removing financial and physical barriers to health care access in India.
With this background the conference "PHARMA Confex 2017” with the theme, "Indian Pharma Sector : Cost Competitiveness and Quality Management” was organised on April 20-21, 2017 at Ahmedabad Management Association, Ahmedabad.
The conference was inaugurated by Dr. Surinder Singh, Director, National Institute of Biologicals, (NIB), Ministry of Health & Family Welfare, Govt. of India, New Delhi. Dr. H. G. Koshia, Commissioner - Licensing Authority (Drug) & Commissioner of Food Safety, Office of the Commissioner, Gandhinagar delivered the special address. The Keynote speaker was Dr. Daara Patel, Secretary General, Indian Drugs Manufacturers Association, Mumbai and Dr. Shirish Belapure, Managing Director, Zydus Hospira Oncology Pvt. Ltd., Ahmedabad was the guest of honour.
The first day inaugural session was followed by 3 technical sessions and 2 on second day. The conference was attended by around 300 delegates consisting of industry, Policy Makers, Regulators, Bulk Drug & Formulation Manufacturers, Biopharmaceutical Companies, Pharma Exporters, R & D Professionals, CMOs and CROs, Health Policy Experts, Pharma / Medical Equipment Makers and Suppliers, Healthcare Consultants, Strategic and Financial Adviser, Bankers /Venture Capitalists, Consultants, Certification Agencies, Academicians /Researcher / Institutions Heads, etc.
The deliberations during the two days were gone a long way in creating awareness. With the encouraging response from industry and professionals, the maiden event was a grand success.
Saket Projects Limited is a multi-disciplinary company involved in creating interactive knowledge based platforms through various activities including publications, conferences as well as exhibitions. The company, over a period of time, has developed strategic strengths and core competencies in the areas of information enhancement and service sector. In the process, it has carved out a niche in the diverse areas of Event Management (Conferences & Exhibitions), Technical Publications and Energy Management.
Since 2004, “SAKET” designs and develops conferences aimed at specific target audience to provide them strategic and timely information on policy initiatives, enhanced business processes, technologies, networking opportunity, shape of things to come etc., understanding the immediate business concerns of today's leading and budding executives. With a continued forward thinking approach, the company has successfully organized events on diverse themes with specialization in industry-specific events.
The Conferences have been actively participated by leaders of the respective sectors from India and abroad as : Speakers, Panel Experts, as well as Delegates.